RIT1 regulates mitosis and promotes proliferation by interacting with SMC3 and PDS5 in hepatocellular carcinoma.

"Declarations Ethics approval and consent to participateAll experiments involving human tissue specimens were approved by the Ethics Committee of Renji Hospital, Shanghai Jiao Tong University School of Medicine (approved number is KY2021-192-B), and informed consent were obtained from all participating patients. Animal studies were approved by the Animal Care and Use Committee of the Renji Hospital, Shanghai Jiao Tong University School of Medicine (approved number was R52022-1025). Consent for publicationNot applicable. Competing interestsThe authors declare no potential conflicts of interest. Competing interests The authors declare no potential conflicts of interest."

"Funding This work was supported by grants from the National Natural Science Foundation of China (82172904, HL), the National Natural Science Foundation of Shanghai (20ZR1454000, HL), the Research Project of Shanghai Municipal Commission of Health and Family Planning (20204Y0093, CM), the Grants from the State Key Laboratory of Systems Medicine for Cancer (zz-94-21-03 and zz-94-2303, HL)."